维普期刊资源整合服务平台（V6.5）

227篇 您的检索式：作者名="Scirica"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction 显示文摘	Gurfinkel EP Scirica BM Bozovich G	1999	Am J Cardiol1999，83，：	1
2	Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events(TRA 2°P)-TIMI 50 trial 显示文摘	MORROW D A SCIRICA B M FOX K A	2009	Am Heart J2009，158，3：	1
3	Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial显示文摘	Benjamin M Scirica Marc P Bonaca Eugene Braunwald Gaetano M De Ferrari Daniel Isaza Basil S Lewis Felix Mehrhof Piera A Merlini Sabina A Murphy Marc S Sabatine Michal Tendera Frans Van de Werf Robert Wilcox David A Morrow	2012	The Lancet . 2012 (9850)2012，，9850：	1
4	The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction ( SAVOR-TIMI ) 53 study 显示文摘	Scirica B M Bhatt D L Braunwald E	2011	Am Heart J2011，162，5：	1
5	Patients with acute coronary syndromes and elevated levels of natriuretic peptides:the results of the AVANT GARDE-TIMI 43 Trial显示文摘	Scirica BM Morrow DA Bode C	2010	Eur Heart J2010，31，16：	1
6	Concentrations of C- reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death显示文摘	Scirica BM Cannon CP Sabatine MS	2009	Clin Chem2009，55，2：	1
7	Acute coronary syndrome:emerging tools for diagnosis and risk assessment显示文摘	Scirica BM		0，，14：	1
8	Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus 显示文摘	Scirica BM Bhatt DL Brannwald E	2013	N Engl J Med2013，369，14：	1
9	Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMIⅢ(1990-1993)and the GUARANTEE(1995-1996)Registries显示文摘	Scirica BM Cannon CP Gibson CM	2002	Crit Pathw Cardiol2002，1，3：	1
10	Evaluation of a novel antiplatetet a- gent for secondary- prevention in patients with a history of atherosclerotic dis- ease: design and rationale for the Thrombin-Reeeptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events ( TRA 2 degrees P) -TIMI 50 trial显示文摘	Morrow DA Scirica BM Fox KA	2009	Am Heart J2009，158，：	1
11	Relationship between nonsustained ven- tricular tachycardia after non - ST - elevation actute coronary syndrome and sudden cardiac death: observations from the metabotic effi-ciency with ranolazine for less ischemia in non - ST - elevation acute coronary syndrome - thrombolysis in myocardial infarction 36 ran- domized controlled trial 显示文摘	Scirica BM Braunwald E Belardinelli L	2010	Circulation2010，122，5：	1
12	Acute coronary syndrome : emerging tools for diagnosis and risk assessment显示文摘	Scirica BM	2010	J Am Coil Cardiol2010，55，：	1
13	The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study 显示文摘	Scirica BM Bhatt DL Braunwald E	2011	Am Heart J2011，162，5：	1
14	Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI Ⅲ registry显示文摘	SCIRICA B M CANNON C P ANTMAN E M	2002	Am J Cardiol2002，90，：	1
15	Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled triM显示文摘	SCIRICA B M MORROW D A HOD H	2007	Circulation2007，116，15：	1
16	Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus ( SAVOR ) -TIMI 53 trial 显示文摘	Mosenzon O Raz I Scirica BM	2013	Diabetes Metab Res Rev2013，29，5：	1
17	Clinical Implications and Correlates of Q Waves in Patients With ST ‐Elevation Myocardial Infarction Treated With Fibrinolysis: Observations from the CLARITY‐TIMI 28 Trial显示文摘	Jonathan W. Waks Marc S. Sabatine Christopher P. Cannon David A. Morrow C. Michael Gibson Stephen D. Wiviott Robert P. Giugliano Sarah Sloan Benjamin M. Scirica	2014	Clin Cardiol2014，，：	1
18	Acute coronary syndrome: emerging tools for diag-nosis and risk assessment显示文摘	Scirica BM	2010	J AM Coll Cardiol2010，55，14：	1
19	Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I显示文摘	Bonaca M Scirica B Sabatine M		0，，19：	1
20	Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus 显示文摘	Scirica BM Bhatt DL Braunwald E	2013	N Engl J Med2013，369，14：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示